Actively Recruiting
Biomarkers of Renal Cancer
Led by Biorek S.R.L. · Updated on 2023-03-27
1000
Participants Needed
4
Research Sites
363 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of the present study is the identification, in liquid biopsies, of a new molecular panel able to discriminate renal cancer patients from controls, to discriminate patients with a malignant lesion from those with a benign mass, to determine aggressiveness of RCC, and to differentiate the most common histological subtypes of RCC (clear cell, papillary 1, papillary 2, and chromophobe). This new molecular panel will be combined with clinical parameters to provide a screening test and to improve the accuracy and specificity of diagnosis, prognosis, and histological classification of renal cancer.
CONDITIONS
Official Title
Biomarkers of Renal Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Men and women over 18 years of age
- Diagnosis of first episode of renal mass
- Caucasian race
- Signed, informed consent
- Men and women over 18 years of age
- Caucasian race
- Living kidney donor or patient with urological functional diseases (e.g., kidney stones, benign prostate hypertrophy)
- Signed, informed consent
You will not qualify if you...
- Any other concomitant cancer or history of active cancer in the last 5 years
- Oncological genetic syndrome
- Previous history of renal tumour
- Urothelial cancer
- End-stage renal disease on hemodialysis
- Bilateral renal cell carcinoma
- History of active cancer in the last 5 years
- Oncological genetic syndrome
- End-stage renal disease on hemodialysis or peritoneal dialysis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
Azienda Ospedaliera Universitaria Careggi
Florence, Italy, 50139
Actively Recruiting
2
IRCCS San Raffaele
Milan, Italy, 20132
Actively Recruiting
3
Azienda Ospedaliera Universitaria San Luigi Gonzaga
Orbassano, Italy, 10043
Actively Recruiting
4
Fundació Puigvert
Barcelona, Spain, 08025
Actively Recruiting
Research Team
F
Francesco Trevisani
CONTACT
A
Alessandra Cinque
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here